Avantor, Inc.
HealthcareNYSE:AVTR · New York Stock Exchange
-$0.27 today
Vol 7.15M · Avg 9.72M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-9.5%
avg 5.5%
ROIC
-2.4%
avg 3.8%
ROA
-4.5%
avg 0.8%
Analysis
ROIC is currently the strongest return metric at -2.4% versus its period average of 3.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Corey D. Walker | President of Laboratory Solutions | $1.06M | — | 48 | $387,545.00 | 0.06% |
R. Brent Jones | Executive Vice President & Chief Financial Officer | $964,912.00 | — | 56 | $419,782.00 | 0.06% |
Emmanuel Ligner | President, Chief Executive Officer & Director | $895,636.00 | — | 55 | $1.90M | 0.28% |
Michael Wondrasch | Executive Vice President & Chief Information Officer | $808,631.00 | — | 57 | $85,821.00 | 0.01% |
Claudius O. Sokenu | Executive Vice President, Corporate Secretary and Chief Legal & Compliance Officer | $798,629.00 | — | 58 | $252,429.00 | 0.04% |
Benoit Gourdier | Executive Vice President of Bioscience Production | $796,003.00 | — | 59 | $362,859.00 | 0.05% |
Steven W. Eck | Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer | — | — | 50 | $130,978.00 | 0.02% |
Chris Fidyk | Vice President of Investor Relations | — | — | — | — | — |
Christophe Couturier | Executive Vice President of AMEA | — | — | 60 | $211,271.00 | 0.03% |
Brittany Hankamer | Executive Vice President & Chief Human Resources Officer | — | — | 55 | $249,045.00 | 0.04% |
Mary Blenn | Executive Vice President & Chief Operating Officer | — | — | — | $1.04M | 0.15% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
9
$9.94M
Sells
1
$39,591.64
Net Sentiment
+$9.90M
Net buying
Most Active
SUMME GREGORY L
3 transactions
Analysis
Insiders reported 9 buys worth $9.94M and 1 sells worth $39,591.64 over the last 12 months. That adds up to net buying of $9.90M. SUMME GREGORY L was the most active insider with 3 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +106.0% | +1.8% (11yr)4 analysts |
| Net Income | N/A | N/A | N/A | +30.5% (11yr)4 analysts |
| EBIT | N/A | N/A | +282.0% | +2.6% (11yr)4 analysts |
Analysis
Recent growth has been strongest in EBIT at +282.0% over three years. Forward estimates point to Net Income at +30.5% (11yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Baxter International Inc.
NYSE:BAX
$10.77B
Molina Healthcare, Inc.
NYSE:MOH
$10.43B
Masimo Corporation
NASDAQ:MASI
$9.42B
Henry Schein, Inc.
NASDAQ:HSIC
$9.26B
Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.73B
AptarGroup, Inc.
NYSE:ATR
$7.51B
Repligen Corporation
NASDAQ:RGEN
$7.37B
Grifols, S.A.
NASDAQ:GRFS
$6.46B
Stevanato Group S.p.A.
NYSE:STVN
$4.66B
Who manages AVTR?
Avantor, Inc. (AVTR) lists 11 active executives. The top listed executive is R. Brent Jones, Executive Vice President & Chief Financial Officer.
Are AVTR insiders buying or selling?
Recent insider activity shows net buying of $106.09M.
Explore More
Continue the stock analysis
Jump to another research area for this company.